ResMed Statistics

Total Valuation

ResMed has a market cap or net worth of GBP 27.69 billion. The enterprise value is 28.02 billion.

Market Cap	27.69B
Enterprise Value	28.02B

Important Dates

The next estimated earnings date is Thursday, January 23, 2025.

Earnings Date	Jan 23, 2025
Ex-Dividend Date	Nov 7, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	145.80M

Valuation Ratios

The trailing PE ratio is 33.35.

PE Ratio	33.35
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	20.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.00, with an EV/FCF ratio of 27.75.

EV / Earnings	33.74
EV / Sales	7.33
EV / EBITDA	21.00
EV / EBIT	23.71
EV / FCF	27.75

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.16.

Current Ratio	2.92
Quick Ratio	1.44
Debt / Equity	0.16
Debt / EBITDA	0.51
Debt / FCF	0.63
Interest Coverage	40.98

Financial Efficiency

Return on equity (ROE) is 23.56% and return on invested capital (ROIC) is 15.72%.

Return on Equity (ROE)	23.56%
Return on Assets (ROA)	13.27%
Return on Capital (ROIC)	15.72%
Revenue Per Employee	359,405
Profits Per Employee	83,199
Employee Count	9,980
Asset Turnover	0.69
Inventory Turnover	1.82

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+31.78%
50-Day Moving Average	242.47
200-Day Moving Average	220.14
Relative Strength Index (RSI)	36.49
Average Volume (20 Days)	1,228

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.94

Income Statement

In the last 12 months, ResMed had revenue of GBP 3.59 billion and earned 830.32 million in profits. Earnings per share was 5.63.

Revenue	3.59B
Gross Profit	2.09B
Operating Income	1.11B
Pretax Income	1.03B
Net Income	830.32M
EBITDA	1.22B
EBIT	1.11B
Earnings Per Share (EPS)	5.63

Full Income Statement

Balance Sheet

The company has 330.21 million in cash and 634.37 million in debt, giving a net cash position of -304.16 million.

Cash & Cash Equivalents	330.21M
Total Debt	634.37M
Net Cash	-304.16M
Net Cash Per Share	n/a
Equity (Book Value)	3.88B
Book Value Per Share	26.41
Working Capital	1.30B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.07 billion and capital expenditures -65.11 million, giving a free cash flow of 1.01 billion.

Operating Cash Flow	1.07B
Capital Expenditures	-65.11M
Free Cash Flow	1.01B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 58.33%, with operating and profit margins of 30.84% and 23.15%.

Gross Margin	58.33%
Operating Margin	30.84%
Pretax Margin	28.62%
Profit Margin	23.15%
EBITDA Margin	33.95%
EBIT Margin	30.84%
FCF Margin	28.15%

Dividends & Yields

This stock pays an annual dividend of 1.58, which amounts to a dividend yield of 0.68%.

Dividend Per Share	1.58
Dividend Yield	0.68%
Dividend Growth (YoY)	7.06%
Years of Dividend Growth	2
Payout Ratio	26.02%
Buyback Yield	-0.02%
Shareholder Yield	0.65%
Earnings Yield	3.09%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ResMed has an Altman Z-Score of 10.95.

Altman Z-Score	10.95
Piotroski F-Score	n/a